OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2022
(2)
2021
(2)
2018
(2)
2023
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer.
Not available
S-EPMC6140817
|
biostudies-literature
Cite
Do invasive plants structure microbial communities to accelerate decomposition in intermountain grasslands?
Not available
S-EPMC5743483
|
biostudies-literature
Cite
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.
Not available
S-EPMC8227457
|
biostudies-literature
Cite
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
Not available
S-EPMC9412846
|
biostudies-literature
Cite
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial.
Not available
S-EPMC5765477
|
biostudies-literature
Cite
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer.
Not available
S-EPMC7957142
|
biostudies-literature
Cite
Acquisition and evolution of enhanced mutualism-an underappreciated mechanism for invasive success?
Not available
S-EPMC9561174
|
biostudies-literature
Cite
Environmental heterogeneity modulates the effect of plant diversity on the spatial variability of grassland biomass.
Not available
S-EPMC10066197
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets